202 related articles for article (PubMed ID: 28574279)
1. Update on Immunohistochemical Analysis in Breast Lesions.
Peng Y; Butt YM; Chen B; Zhang X; Tang P
Arch Pathol Lab Med; 2017 Aug; 141(8):1033-1051. PubMed ID: 28574279
[TBL] [Abstract][Full Text] [Related]
2. Applications and limitations of immunohistochemical expression of "Napsin-A" in distinguishing lung adenocarcinoma from adenocarcinomas of other organs.
Kadivar M; Boozari B
Appl Immunohistochem Mol Morphol; 2013 May; 21(3):191-5. PubMed ID: 22914608
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of androgen receptor and GATA binding protein 3 as immunohistochemical markers in the diagnosis of metastatic breast carcinoma to the lung.
Hattori Y; Yoshida A; Yoshida M; Takahashi M; Tsuta K
Pathol Int; 2015 Jun; 65(6):286-92. PubMed ID: 25727644
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic utility of the triple markers Napsin A, TTF-1, and PAX8 in differentiating between primary and metastatic lung carcinomas.
El-Maqsoud NM; Tawfiek ER; Abdelmeged A; Rahman MF; Moustafa AA
Tumour Biol; 2016 Mar; 37(3):3123-34. PubMed ID: 26427663
[TBL] [Abstract][Full Text] [Related]
5. SOX10, GATA3, GCDFP15, Androgen Receptor, and Mammaglobin for the Differential Diagnosis Between Triple-negative Breast Cancer and TTF1-negative Lung Adenocarcinoma.
Laurent E; Begueret H; Bonhomme B; Veillon R; Thumerel M; Velasco V; Brouste V; Hoppe S; Fournier M; Grellety T; MacGrogan G
Am J Surg Pathol; 2019 Mar; 43(3):293-302. PubMed ID: 30628926
[TBL] [Abstract][Full Text] [Related]
6. Significantly increased PELP1 protein expression in primary and metastatic triple-negative breast carcinoma: comparison with GATA3 expression and PELP1's potential role in triple-negative breast carcinoma.
Dang DN; Raj G; Sarode V; Molberg KH; Vadlamudi RK; Peng Y
Hum Pathol; 2015 Dec; 46(12):1829-35. PubMed ID: 26428280
[TBL] [Abstract][Full Text] [Related]
7. Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas.
Shi J; Liu H; Ma XJ; Chen Z; He MX; Luo Y; Lin F
Arch Pathol Lab Med; 2016 Apr; 140(4):332-40. PubMed ID: 27028392
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung.
Ye J; Hameed O; Findeis-Hosey JJ; Fan L; Li F; McMahon LA; Yang Q; Wang HL; Xu H
Biotech Histochem; 2012 Jan; 87(1):30-4. PubMed ID: 21838611
[TBL] [Abstract][Full Text] [Related]
9. Rapid Immunohistochemistry With Thyroid Transcription Factor-1 for Pulmonary Adenocarcinoma.
Konno H; Saito H; Nanjo H; Hiroshima Y; Kurihara N; Fujishima S; Atari M; Sato Y; Motoyama S; Nakamura R; Akagami Y; Minamiya Y
Ann Thorac Surg; 2017 Aug; 104(2):471-476. PubMed ID: 28527968
[TBL] [Abstract][Full Text] [Related]
10. Application of immunohistochemistry in breast pathology: a review and update.
Liu H
Arch Pathol Lab Med; 2014 Dec; 138(12):1629-42. PubMed ID: 25427042
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous carcinomas of the breast and ovary: utility of Pax-8, WT-1, and GATA3 for distinguishing independent primary tumors from metastases.
Espinosa I; Gallardo A; D'Angelo E; Mozos A; Lerma E; Prat J
Int J Gynecol Pathol; 2015 May; 34(3):257-65. PubMed ID: 25844549
[TBL] [Abstract][Full Text] [Related]
12. Utility of folate receptor alpha immunohistochemistry in cytology specimens of metastatic breast carcinoma, metastatic serous carcinoma of Müllerian origin, and primary lung adenocarcinoma.
Sheikh UN; Cohen C; Siddiqui MT
Diagn Cytopathol; 2016 May; 44(5):369-76. PubMed ID: 26875861
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical Surrogates for Molecular Classification of Breast Carcinoma: A 2015 Update.
Tang P; Tse GM
Arch Pathol Lab Med; 2016 Aug; 140(8):806-14. PubMed ID: 27472239
[TBL] [Abstract][Full Text] [Related]
14. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung.
Ye J; Findeis-Hosey JJ; Yang Q; McMahon LA; Yao JL; Li F; Xu H
Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):313-7. PubMed ID: 21464700
[TBL] [Abstract][Full Text] [Related]
15. Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: a clinicopathologic and immunohistochemical study.
Plaza JA; Mackinnon A; Carrillo L; Prieto VG; Sangueza M; Suster S
Am J Dermatopathol; 2015 Nov; 37(11):809-21. PubMed ID: 26485238
[TBL] [Abstract][Full Text] [Related]
16. Folate Receptor Alpha Immunohistochemistry in Cytology Specimens of Metastatic Breast Carcinoma.
Sheikh UN; Cohen C; Siddiqui MT
Acta Cytol; 2015; 59(4):298-304. PubMed ID: 26413911
[TBL] [Abstract][Full Text] [Related]
17. Utility of TTF-1 and Napsin-A in the work-up of malignant effusions.
El Hag M; Schmidt L; Roh M; Michael CW
Diagn Cytopathol; 2016 Apr; 44(4):299-304. PubMed ID: 26799356
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of GATA3 expression in invasive breast cancer: differences in histological subtypes and immunohistochemically defined molecular subtypes.
Shaoxian T; Baohua Y; Xiaoli X; Yufan C; Xiaoyu T; Hongfen L; Rui B; Xiangjie S; Ruohong S; Wentao Y
J Clin Pathol; 2017 Nov; 70(11):926-934. PubMed ID: 28428285
[TBL] [Abstract][Full Text] [Related]
19. An immunohistochemical panel to differentiate metastatic breast carcinoma to skin from primary sweat gland carcinomas with a review of the literature.
Rollins-Raval M; Chivukula M; Tseng GC; Jukic D; Dabbs DJ
Arch Pathol Lab Med; 2011 Aug; 135(8):975-83. PubMed ID: 21809988
[TBL] [Abstract][Full Text] [Related]
20. GATA-3 and FOXA1 expression is useful to differentiate breast carcinoma from other carcinomas.
Davis DG; Siddiqui MT; Oprea-Ilies G; Stevens K; Osunkoya AO; Cohen C; Li XB
Hum Pathol; 2016 Jan; 47(1):26-31. PubMed ID: 26527523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
